Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia

Foon, 1984, Acute myelogenous leukemia: current status of therapy in adults, Vol. 93, 216 Casazza, 1979, Antileukemic activity and cardiac toxicity of 4-demethoxydaunorubicin (4-DMD) in mice, 20, 16 Casazza, 1980, Antileukemic activity of 4-demethoxydaunorubicin in mice, Tumori, 66, 549, 10.1177/030089168006600503 Ganzina, 1986, Idarubicin (4-demethoxydaunorubicin), 4, 85 Berman, 1986, Idarubicin in the treatment of acute leukemia: phase I, II and III studies, Vol. 1, 298 Harousseau, 1986, Phase II study of idarubicin in relapsed or refractory acute leukemia (AL): preliminary results. Workshop No. M-2: Recent results with idarubicin in acute leukaemias, 276 Lambertenghi-Deliliers, 1983, Therapeutic actvity of 4-demethoxydaunorubicin (idarubicin) in adult acute leukemia, Tumori, 69, 515, 10.1177/030089168306900605 Casazza, 1983, Biologic activity of 4-demethoxy-13-dihydro-daunorubicin (4-DM-13-OH-DNR), 24, 251 Goldberg, 1985, Treatment of patients with acute nonlymphocytic leukemia in relapse: a leukemia intergroup study, Am J Hematol, 19, 167, 10.1002/ajh.2830190209 Herzig, 1985, High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia, J Clin Oncol, 3, 992, 10.1200/JCO.1985.3.7.992 Giuliani, 1983, Preclinical studies on new anthracyclines: antitumor, toxicologic and pharmacologic properties, 192 Lambertenghi-Deliliers, 1984, Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine, Cancer, 54, 199, 10.1002/1097-0142(19840715)54:2<199::AID-CNCR2820540203>3.0.CO;2-V Lambertenghi-Deliliers, 1986, Intravenous and oral idarubicin in acute leukemia. Workshop No. M-2: Recent results with idarubicin in acute leukaemias, 276 Mandelli, 1986, A multicentric comparative phase III trial of idarubicin and Ara-C versus Daunorubicin and ARA-C in acute non-lymphoblastic leukemia of aging patients, Vol. 1, 299 Duffy, 1985, How much is too much high-dose cytosine arabinoside?, J Clin Oncol, 3, 601, 10.1200/JCO.1985.3.5.601